Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
J Pharmacol Sci. 2020 Dec;144(4):204-211. doi: 10.1016/j.jphs.2020.09.001. Epub 2020 Sep 10.
The deficiency of survival motor neuron (SMN) protein can result in the onset of spinal muscular atrophy (SMA), an autosomal recessive disorder characterized by a progressive loss of motor neurons and skeletal muscle atrophy. The mechanism underlying SMA pathology remains unclear. Here, we demonstrate that SMN protein regulates oxidative stress and inflammatory response in microglia. Antisense oligonucleotide, which increases SMN protein expression (SMN-ASO), attenuated SMA model mice phenotypes and suppressed the activation of microglia in the spinal cord. The expression of oxidative stress marker in microglia was decreased by SMN-ASO injection in SMA model mice. Increased reactive oxygen species production and subsequent antioxidative stress reaction was observed in SMN protein-depleted RAW264.7. Furthermore, nuclear factor kappa B (NFκB) and c-Jun amino terminal kinase (JNK) signaling, which mainly mediate the inflammatory response, are activated in SMN protein-depleted RAW264.7. Tumor necrosis factor-α (TNF-α) production is also increased in SMN protein-depleted RAW264.7. These findings suggest that SMN protein regulates oxidative stress and inflammatory response in microglia, supporting current claims that microglia can be an effective target for SMA therapy.
运动神经元存活蛋白(SMN)的缺乏可导致脊髓性肌萎缩症(SMA)的发生,这是一种常染色体隐性遗传病,其特征是运动神经元逐渐丧失和骨骼肌萎缩。SMA 发病机制尚不清楚。在这里,我们证明 SMN 蛋白可调节小胶质细胞中的氧化应激和炎症反应。增加 SMN 蛋白表达的反义寡核苷酸(SMN-ASO)可减轻 SMA 模型小鼠的表型,并抑制脊髓中小胶质细胞的激活。SMN-ASO 注射可降低 SMA 模型小鼠小胶质细胞中氧化应激标志物的表达。在 SMN 蛋白耗尽的 RAW264.7 细胞中观察到活性氧(ROS)产生增加和随后的抗氧化应激反应。核因子 kappa B(NFκB)和 c-Jun 氨基末端激酶(JNK)信号通路主要介导炎症反应,在 SMN 蛋白耗尽的 RAW264.7 细胞中被激活。SMN 蛋白耗尽的 RAW264.7 细胞中肿瘤坏死因子-α(TNF-α)的产生也增加。这些发现表明,SMN 蛋白可调节小胶质细胞中的氧化应激和炎症反应,支持小胶质细胞可作为 SMA 治疗的有效靶点的现有观点。